Scientists have developed a method to reprogram cancer-fighting immune cells directly inside the body, potentially ...

Researchers at the University of California have developed a method to engineer cancer-fighting T cells that bypasses costly ...

Prostate cancer affects one in five Australian men, making it the most common cancer in the country. Now, researchers at the ...

A new form of CAR T kills leukemia, multiple myeloma, and sarcoma in mice, opening the door to a future off-the-shelf cancer ...

A technique that transforms immune cells into cancer-seeking bloodhounds may overcome a roadblock that has hampered immunotherapy for solid tumors, according to a new study by Stanford Medicine ...

The current path to CAR-T cell therapy is, by any measure, a logistical ordeal. A patient’s immune cells must be drawn out of ...

Ho: Looking ahead, there are several areas that seem particularly promising. Advances in robotic bronchoscopy platforms, ...

For decades, we’ve fought cancer with the “Big Three”: surgery, chemo, and radiation. It’s often been a brutal trade-off — to ...

Small cell lung cancer (SCLC) is rarer than non-small cell lung cancer (NSCLC) but tends to be more difficult to treat. SCLC can be more resistant and aggressive than other cancers, which can increase ...

ORR 35.8% overall, 37.5% in second-/third-line, and 47.1% in light/nonsmokers, with median DOR not reached in key subsets.

Oropharyngeal cancer is a type of head and neck cancer. It affects the cells in the middle part of your throat, or what’s called the oropharynx. Early signs are easy to miss. “We can't see that area ...